How it works?

PD-L1 SCORING IN DIFFERENT ENTITIES 


DESCRIPTION

PD Dr. Med. Christiane Kümpers

Institute of Pathology, University Hospital Schleswig-Holstein, Luebeck, Germany

Back



RELATED ARTICLES

Pak1 pathway involvment in ER+ breast cancer...

et al. Stefania Belli...


Breast Cancer
Micromount

Abstract Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have been approved in combination with endocrine therapy (ET) to treat estrogen […]...



Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolis...

et al. Riju Roy Chowdhury...


Chemico-Biological Interactions
Hematoxylin

Cylindrospermopsin, a potent hepatotoxin produced by harmful cyanobacterial blooms, poses environmental and human health concerns. We used a 3D human [&hel...



Diapath Lab Talks | Privacy Policy